K. Watson

D. Famini, K. Clothier, A. Mete, 2021, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

Pregnancy outcome in women who were exposed to anti-tumor necrosis factor agents: results from a national population register.

A. Silman, D. Symmons, K. Hyrich, 2006, Arthritis and rheumatism.

The influence of TNF inhibitors on dementia incidence in patients with rheumatoid arthritis; an analysis from the BSRBR‐RA

B. McGuinness, C. Holmes, K. Hyrich, 2018, International journal of geriatric psychiatry.

OP0229 The association of biologic drug-levels with infection risk: results from the british society for rheumatology biologics register for rheumatoid arthritis

W. Dixon, A. Barton, A. Morgan, 2018, FRIDAY, 15 JUNE 2018.

OP0029 The Risk of Serious Infections in Patients Receiving Rituximab for Rheumatoid Arthritis

D. Symmons, M. Lunt, K. Hyrich, 2014 .

Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register

W. Dixon, M. Lunt, A. Ustianowski, 2011, Annals of the rheumatic diseases.

Soddy, Frederick (1877–1956)

K. Watson, 2007 .

Pregnancy experience in women with rheumatic diseases exposed to biologic agents: Results from the BSR biologics register

A. Silman, W. Dixon, K. Watson, 2006 .

Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registers.

D. Symmons, M. Neovius, J. Askling, 2011, Rheumatology.

Influence of anti-tnf therapy and previous malignancy on cancer incidence in patients with Rheumatoid Arthritis (RA): Results from the BSR biologics register (BSRBR)

A. Silman, W. Dixon, M. Lunt, 2006 .

Forensic Medicine in Western Society: A History

K. Watson, 2010 .

CHAPTER 1 – History

Philip Wexler, Katherine D. Watson, Janet M. Everitt, 2000 .

Was Jack the Ripper a Slaughterman? Human-Animal Violence and the World’s Most Infamous Serial Killer

A. Knight, K. Watson, 2017, Animals : an open access journal from MDPI.

Infanticide, Religion And Community in the British Isles, 1720–1920: Introduction

K. Watson, A. Kilday, 2008 .

Dalton's disputed nitric oxide experiments and the origins of his atomic theory.

D. G. Leaist, K. Watson, M. Usselman, 2008, Chemphyschem : a European journal of chemical physics and physical chemistry.

Assaulting the Past Violence and Civilization in Historical Context

K. Watson, 2022 .

Poisoning Crimes and Forensic Toxicology Since the 18th Century

K. Watson, 2020, Academic forensic pathology.

Comment on: Modelling the cost effectiveness of TNF antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry

D. Symmons, A. Brennan, N. Bansback, 2008 .

Modelling the cost effectiveness of TNF-alpha antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry.

A. Brennan, N. Bansback, J. Madan, 2007, Rheumatology.

The British Society for Rheumatology Biologics Register

A. Silman, D. Symmons, I. Griffiths, 2005, Annals of the rheumatic diseases.

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register

W. Dixon, K. Hyrich, D. Symmons, 2008, Annals of the rheumatic diseases.

The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the BSRBR-RA

D. Symmons, M. Lunt, J. Závada, 2013, Annals of the rheumatic diseases.

Chemical warfare agents: toxicology and treatment

Katherine D Watson, K. Watson, 1997, Medical History.

Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register

D. Symmons, P. Noyce, D. Ashcroft, 2009, Arthritis research & therapy.

Long-term persistence with rituximab in patients with rheumatoid arthritis

J. Sergeant, M. Lunt, K. Hyrich, 2018, Rheumatology.

Long-term persistence of TNF-inhibitor treatment in patients with psoriatic arthritis. Data from the British Society for Rheumatology Biologics Register

D. Symmons, K. Hyrich, K. Watson, 2018, RMD Open.

Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti–tumor necrosis factor therapies

D. Symmons, P. Noyce, D. Ashcroft, 2010, Arthritis care & research.

Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study.

A. Silman, D. Symmons, M. Lunt, 2007, Arthritis and rheumatism.

Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register

D. Symmons, T. Farragher, M. Lunt, 2009, Rheumatology.

Extended Report

Mark Lunt, Deborah P M Symmons, D. Symmons, 2022 .

Rituximab or a second anti–tumor necrosis factor therapy for rheumatoid arthritis patients who have failed their first anti–tumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics Register

D. Symmons, M. Lunt, D. Ashcroft, 2012, Arthritis care & research.

Effectiveness of Rituximab in Patients with Rheumatoid Arthritis: Observational Study from the British Society for Rheumatology Biologics Register

D. Symmons, M. Lunt, D. Ashcroft, 2012, The Journal of Rheumatology.

Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register

D. Symmons, P. Noyce, D. Ashcroft, 2016, Rheumatology.

Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug

W. Dixon, D. Symmons, M. Lunt, 2008, Rheumatology.

Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register

D. Symmons, P. Noyce, D. Ashcroft, 2010, Rheumatology.

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

W. Dixon, M. Lunt, A. Ustianowski, 2009, Annals of the rheumatic diseases.

The British Society for Rheumatology Biologics Register. Ann Rheum Dis 2005;64 Suppl 4:iv42–3

A. Silman, W. Dixon, D. Symmons, 2022 .

Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.

A. Silman, W. Dixon, D. Symmons, 2006, Arthritis and rheumatism.

Pregnancy outcomes in women with rheumatoid arthritis ever treated with rituximab.

D. Symmons, K. Hyrich, D. De Cock, 2017, Rheumatology.

Predictors of Response to Anti-tnf-therapy among Patients with Rheumatoid Arthritis: Results from the British Society for Rheumatology Biologics Register

A. Silman, D. Symmons, K. Hyrich, 2022 .

Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register

D. Symmons, M. Lunt, K. Hyrich, 2013, Rheumatology.

K. Hyrich, D. Cock, K. Watson, 2017 .

Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008

D. Symmons, M. Lunt, K. Hyrich, 2010, Rheumatology.

SPECIAL ARTICLE: DRUG SAFETY IN THE RHEUMATIC DISEASES Influence of Anti–Tumor Necrosis Factor Therapy on Cancer Incidence in Patients With Rheumatoid Arthritis Who Have Had a Prior Malignancy: Results From the British Society for Rheumatology

W. Dixon, D. Symmons, M. Lunt, 2022 .

Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population

W. Dixon, D. Symmons, M. Lunt, 2012, Rheumatology.

Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

D. Symmons, M. Lunt, K. Hyrich, 2017, Rheumatology.

Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

W. Dixon, D. Symmons, M. Lunt, 2014, Annals of the rheumatic diseases.

The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register

W. Dixon, D. Symmons, A. Green, 2012, Annals of the rheumatic diseases.

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register

A. Silman, W. Dixon, D. Symmons, 2007, Arthritis and rheumatism.

Predictors of low back pain in British schoolchildren: a population-based prospective cohort study.

A. Silman, D. Symmons, G. Macfarlane, 2003, Pediatrics.

Low back pain in schoolchildren: occurrence and characteristics

A. Silman, D. Symmons, G. Macfarlane, 2002, Pain.

Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

A. Silman, D. Symmons, K. Hyrich, 2006, Arthritis and rheumatism.

Religion, Community and The Infanticidal Mother: Evidence From 1840s Rural Wiltshire

K. Watson, 2008 .

Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis

D. Symmons, N. Bansback, M. Lunt, 2010, Health and quality of life outcomes.

The influence of behavioural and psychological factors on medication adherence over time in rheumatoid arthritis patients: a study in the biologics era

I. Bruce, D. Symmons, L. Cordingley, 2015, Rheumatology.

Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

W. Dixon, D. Symmons, M. Lunt, 2016, Annals of the rheumatic diseases.

Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis

Mark Lunt, William G Dixon, W. Dixon, 2017, Annals of the rheumatic diseases.

Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid Arthritis

W. Dixon, D. Symmons, M. Lunt, 2016, Arthritis & rheumatology.

No Evidence of Association Between Anti–Tumor Necrosis Factor Treatment and Mortality in Patients With Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register

W. Dixon, D. Symmons, M. Lunt, 2010, Arthritis and rheumatism.

Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

A. Silman, K. Hyrich, D. Symmons, 2004, Annals of the rheumatic diseases.

Marcus, Rudolph Arthur

K. Watson, 2001 .

Toxic Histories: Poison and Pollution in Modern India

K. Watson, 2017, Ambix.

Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register

A. Silman, K. Hyrich, D. Symmons, 2005, Annals of the rheumatic diseases.

Extended Report

W. Dixon, M. Lunt, D. Symmons, 2022 .

Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register

D. Symmons, M. Lunt, K. Hyrich, 2010, Rheumatology.

Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register

W. Dixon, D. Symmons, M. Lunt, 2012, Annals of the rheumatic diseases.

Women, violent crime and criminal justice in Georgian Wales

K. Watson, 2013, Continuity and Change.

Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

J. Isaacs, M. Lunt, K. Hyrich, 2018, Annals of the rheumatic diseases.

Medical Negligence in Victorian Britain: The Crisis of Care Under the English Poor Law, c.1834-1900

K. Watson, 2016 .

Effectiveness and safety of TNF inhibitors in adults with juvenile idiopathic arthritis

D. Symmons, M. Lunt, K. Hyrich, 2016, RMD Open.

Anti-TNF therapy and mortality in rheumatoid arthritis patients registered with the British Society for Rheumatology Biologics Register (BSRBR)

A. Silman, K. Watson, K. Hyrich, 2005 .

Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register

D. Symmons, K. Hyrich, K. Watson, 2018, Rheumatology.

Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity

D. Symmons, M. Lunt, K. Hyrich, 2009, Rheumatology.

087 Refractory disease in rheumatoid arthritis: results from the British Society of Rheumatology Biologics Register for rheumatoid arthritis

J. Isaacs, K. Hyrich, M. Buch, 2018 .

D. Cock, K. Watson, K. Hyrich, 2017 .

Response to: ‘Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?’ by Nocturne et al

W. Dixon, D. Symmons, M. Lunt, 2016, Annals of the rheumatic diseases.

O10. Risk and Characteristics of Drug-Induced Lupus in Patients Exposed to Tumour Necrosis Factor-α Inhibitor Therapy: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

W. Dixon, A. Barton, I. Bruce, 2015 .

Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti‑TNF therapy: results from the British Society for Rheumatology Biologics Register

D. Symmons, M. Lunt, J. Galloway, 2011 .

198. MORTALITY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INTERSTITIAL LUNG DISEASE TREATED WITH TUMOUR NECROSIS FACTOR INHIBITOR OR RITUXIMAB

D. Symmons, K. Hyrich, K. Druce, 2017 .

Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register

D. Symmons, P. Noyce, D. Ashcroft, 2009, Arthritis research & therapy.

Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register

D. Symmons, P. Noyce, D. Ashcroft, 2010, Rheumatology.

Brown, Herbert Charles

K. Watson, 2001 .

Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

D. Symmons, M. Lunt, D. Ashcroft, 2011, Annals of the Rheumatic Diseases.

The role of the British Society for Rheumatology Biologics Register (BSRBR) and the NICE guidelines for anti-TNF therapy.

K. Hyrich, K. Watson, 2003, Musculoskeletal care.

Toxicology, History of

K. Watson, 2005 .

The Chemist as Expert: The Consulting Career of Sir William Ramsay

Katherine D. Watson, K. Watson, 1995 .

Association between anti-tumour necrosis factor therapy and risk of ischaemic stroke in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registers-Rheumatoid Arthritis (BSRBR-RA)

W. Dixon, D. Symmons, M. Lunt, 2013, The Lancet.

Poisoned Lives: English Poisoners and Their Victims

K. Watson, 2004 .

Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

W. Dixon, D. Symmons, M. Lunt, 2014, Annals of the rheumatic diseases.

Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

A. Silman, K. Hyrich, D. Symmons, 2004, Annals of the rheumatic diseases.

BHPR: Audit and Clinical Evaluation103. Dental Health in Children and Young Adults with Inflammatory Arthritis: Access to Dental Care

T. Spector, D. Lawlor, D. Ray, 2013 .